Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07336550
Eligibility Criteria:
PRIMARY CARE CENTERS IN THE BARAKALDO-SESTAO INTEGRATED HEALTHCARE ORGANISATION OF OSAKIDETZA-BASQUE HEALTH SERVICE:
Inclusion Criteria:
* collaboration is achieved from at least 51% of the General Practitioners (GP) or at least 4 GPs
* At least 60 patients aged 65 years or older on at least one of the drugs of interest that may be potentially inappropriately prescribed
Exclusion Criteria:
* N/A
PATIENTS ASSIGNED TO THE PARTICIPATING PC CENTERS:
Inclusion Criteria:
* Patients over 65 years of age with any of the following unsuitability criteria:
* PIP of benzodiazepines: patients on benzodiazepines for more than 3 months
* PIP of proton pump inhibitors: patients on proton pump inhibitors for more than 8 weeks without a diagnosed gastrointestinal disease and with no long-term prescription of gastrotoxic drugs.
* PIP of opioids: patients on opioids for non-cancer pain for more than 3 months.
Exclusion Criteria:
* Patients who, in the opinion of the general practitioner, are not suitable candidates for tapering or discontinuation of the potentially inappropriately prescribed drug
* Patients residing in care homes
* Patients receiving palliative care
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT07336550
Study Brief:
Protocol Section:
NCT07336550